Tabe 4.
IMDC risk group criteria for OS in nccRCC
| Univariate analysis | Multivariable model* | |||
|---|---|---|---|---|
| Parameter | HR (95% CI) | p-value | HR (95% CI) | p-value |
| Hb low (<LLN) | 1.72(1.23,2.40) | 0.002 | 1.48(1.03,2.14) | 0.034 |
| Neutrophilia (>ULN) | 3.23(2.24,4.65) | <.0001 | 2.43(1.58,3.74) | <.0001 |
| KPS <80 | 3.15(2.23,4.45) | <.0001 | 2.02(1.35,3.02) | 0.0006 |
| Thrombophilia (>ULN) | 2.56(1.80,3.63) | <.0001 | 1.13(0.72,1.79) | 0.592 |
| Hypercalcaemia (>ULN) | 2.13(1.24,3.65) | 0.006 | 1.42(0.78,2.60) | 0.256 |
| Dx to treatment initiation <1year | 1.53(1.12,2.07) | 0.007 | 1.22(0.87,1.71) | 0.251 |
Abbreviations: Hb= hemoglobin, KPS= Karnofski performance status, Dx= diagnosis, ULN= upper limit of normal, LLN= lower limit of normal
c-index of 0.70 (95% CI: 0.66-0.74),